DL Pharma + SRL
DL Pharma + reported total assets of 18,667 € at the end of the 2026 financial year (annual accounts filed with the NBB on 10 Oct 2026).
The score of DL Pharma + shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity -43 % Total assets -42 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DL Pharma +'s annual accounts
Filed annual accounts
- Year ended 31 Mar 2026filed on 10 Oct 2026
- Year ended 31 Mar 2025filed on 31 Oct 2025
- Year ended 31 Mar 2024filed on 25 Sep 2024
- Year ended 31 Mar 2023filed on 27 Oct 2023
- Year ended 31 Mar 2022filed on 26 Oct 2022
DL Pharma +'s financial analysis
- Solvency59.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DL Pharma +
DL Pharma +'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0755.325.637
- VAT number
- BE0755325637
- Peppol
- Registered · 0208:0755325637 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Sep 2020
- Registered office
- 9870 Zulte
- Latest accounts
- 2026 · filed on 10 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
DL Pharma + (SRL) has been based in Zulte since 2020, active in: retail sale of pharmaceutical products. For 2026, it reports a net profit of 84 € and equity of 11,109 €; its revenue is not published. Its solvency stands at 59.5%, above the median of its sector (44.2%).
Companies similar to DL Pharma +
Companies in the same business, of comparable size and area, outside its group.
- MayBeDo Business and other management consultancy activities Wavre · balance sheet 16,662 €
- Lintström Business and other management consultancy activities Schilde · balance sheet 64,321 €
- Galeni K. Business and other management consultancy activities Zutendaal · balance sheet 67,285 €
- Novafontis Business and other management consultancy activities Liège · balance sheet 131,719 €
- NE Consult Retail sale of pharmaceutical products Rixensart · balance sheet 15,960 €
- Formapharma Retail sale of pharmaceutical products Andenne · balance sheet 17,739 €
- Styrax Retail sale of pharmaceutical products Merchtem · balance sheet 37,073 €
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
Frequently asked questions about DL Pharma +
What is the revenue of DL Pharma +?
DL Pharma + files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of DL Pharma +?
In Belgium, the VAT number is the company number prefixed with BE: BE0755325637 for DL Pharma +, if the company is VAT-registered. Its company number (CBE) is 0755.325.637.
Where is the registered office of DL Pharma +?
According to the CBE register, the registered office of DL Pharma + is in 9870 Zulte.
What is the equity of DL Pharma +?
At the close of the 2026 financial year, the equity of DL Pharma + amounts to 11,109 €, a solvency of 59.5% of total assets.
Who manages DL Pharma +?
The register lists 1 active mandates at DL Pharma +. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DL Pharma +
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →